Find Amifampridine Phosphate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Zenas, 3,4-diaminopyridine phosphate, 446254-47-3, Firdapse (tn), Amifampridine phosphate [mi], 3,4-pyridinediamine, phosphate (1:1)
Molecular Formula
C5H10N3O4P
Molecular Weight
207.12  g/mol
InChI Key
KAICRBBQCRKMPO-UHFFFAOYSA-N
FDA UNII
8HF8FIN815

Amifampridine Phosphate
4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
1 2D Structure

Amifampridine Phosphate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
phosphoric acid;pyridine-3,4-diamine
2.1.2 InChI
InChI=1S/C5H7N3.H3O4P/c6-4-1-2-8-3-5(4)7;1-5(2,3)4/h1-3H,7H2,(H2,6,8);(H3,1,2,3,4)
2.1.3 InChI Key
KAICRBBQCRKMPO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CN=CC(=C1N)N.OP(=O)(O)O
2.2 Other Identifiers
2.2.1 UNII
8HF8FIN815
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3,4 Diaminopyridine

2. 3,4-diaminopyridine

3. Amifampridine

4. Firdapse

5. Ruzurgi

2.3.2 Depositor-Supplied Synonyms

1. Zenas

2. 3,4-diaminopyridine Phosphate

3. 446254-47-3

4. Firdapse (tn)

5. Amifampridine Phosphate [mi]

6. 3,4-pyridinediamine, Phosphate (1:1)

7. Amifampridine Phosphate [usan]

8. Amifampridine Phosphate [mart.]

9. Amifampridine Phosphate [who-dd]

10. 446254-47-3 (phosphate)

11. Amifampridine (phosphate)

12. Amifampridine Phosphate [ema Epar]

13. 3,4-dapp

14. 8hf8fin815

15. Pyridine-3,4-diamine Phosphate

16. Amifampridine Phosphate (usan)

17. Unii-8hf8fin815

18. Phosphoric Acid;pyridine-3,4-diamine

19. Starbld0005260

20. Schembl3958357

21. Chembl3301611

22. Dtxsid40196254

23. Hy-14946a

24. Amifampridine Phosphate [orange Book]

25. Cs-0009524

26. 3,4-diaminopyridin-1-ium Dihydrogen Phosphate

27. D10689

28. Q27270515

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 207.12 g/mol
Molecular Formula C5H10N3O4P
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count0
Exact Mass207.04089281 g/mol
Monoisotopic Mass207.04089281 g/mol
Topological Polar Surface Area143 Ų
Heavy Atom Count13
Formal Charge0
Complexity124
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Neuromuscular Agents

Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. (See all compounds classified as Neuromuscular Agents.)


Potassium Channel Blockers

A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
Potassium Channel Blocker [EPC]; Potassium Channel Antagonists [MoA]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700073000,"product":"AMIFAMPRIDINE PHOSPHATE API","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"TEVA PHARMACEUTICAL INDUSTRIES","supplierCountry":"INDIA","foreign_port":"WASHINGTON","customer":"STERNE, KESSLER, GOLDSTEIN & FOX","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"35.9","totalValueFC":"360.3","currency":"USD","unitRateINR":3000,"date":"16-Nov-2023","totalValueINR":"30000","totalValueInUsd":"360.3","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"5377791","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"21-22, KALPATARU SQUARE, KONDIVITA, ANDHERI (E), MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660156200,"product":"AMIFAMPRIDINE PHOSPHATE GMP (AS PER INV)","address":"SURVEY NO.42, GADDAPOTHARAM,KAZIPA LLY IND AREA, SANGAREDDY DIST","city":"GADDAPOTHARAM HYD,TELANGANA","supplier":"CHIRACON GMBH","supplierCountry":"GERMANY","foreign_port":"NA","customer":"TIEFENBACHER API + INGREDIENTS GMBH","customerCountry":"INDIA","quantity":"4.80","actualQuantity":"4.8","unit":"KGS","unitRateFc":"35500","totalValueFC":"176038.5","currency":"EUR","unitRateINR":"2918100","date":"11-Aug-2022","totalValueINR":"14006880","totalValueInUsd":"176038.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9967736","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SURVEY NO.42, GADDAPOTHARAM,KAZIPA LLY IND AREA, SANGAREDDY DIST"}]
11-Aug-2022
16-Nov-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty